Skip to main content
. Author manuscript; available in PMC: 2008 Feb 15.
Published in final edited form as: J Infect Dis. 2007 Apr 5;195(10):1472–1479. doi: 10.1086/514821

Table 2.

Prevalence of factor H–binding protein (fHBP) isolates, by fHBP phenotype.

fHBP phenotypea fHBP variant Isolates, %b Prototype strain Predominant STc (ET) complex
111-000 1 70 MC58 ST-32 (ET-5)
011-000 1 9 4243 Heterogeneous
011-100 1 10 NZ98/254 Heterogeneous
Other v.1 1 11 None None
000-111 2 or 3 20 2996 ST-35 complex
000-110 2 24 MD01158 ST-41/44 (lineage III)
000-001 2 or 3 12 M1239 ST-162 complex
000-000 2 44 RM1090 Heterogeneous
a

Pattern of fHBP monoclonal antibody (MAb) reactivity in the order JAR 1, 3, 5 (anti–variant [v.] 1 MAbs) and JAR 10, 11, 13 (anti-v.2 MAbs); 1 indicates reactivity, and 0 indicates no reactivity.

b

Among v.1 or among v.2 and v.3 isolates, respectively.

c

Multilocus sequence type (ST), per the Multi Locus Sequence Typing database (available at: http://www.mlst.net) [38]. “Predominant” implies that ≥50% of isolates had the specified ST.